Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Starling Oncology, Inc. (STLN) reports that reporting person Jorey Chernett beneficially owned 5,934,872 shares as of November 13, 2026, equal to approximately 5.6% of the class. The amount consisted of 2,641,272 shares held directly and 3,293,600 shares issuable upon exercise of call options exercisable within 60 days. The option shares are deemed outstanding for the beneficial-ownership calculation.
Key Figures
Beneficial ownership:5,934,872 sharesDirectly held shares:2,641,272 sharesShares issuable upon call-option exercise:3,293,600 shares+1 more
4 metrics
Beneficial ownership5,934,872 sharesJorey Chernett's reported amount as of November 13, 2026
Directly held shares2,641,272 sharesIncluded in Jorey Chernett's reported beneficial ownership
Shares issuable upon call-option exercise3,293,600 sharesOptions exercisable within 60 days
Beneficial ownership percentageApproximately 5.6%Percentage of the class reported as of November 13, 2026
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
call optionsfinancial
"issuable upon exercise of call options"
A call option is a contract that gives its buyer the right, but not the obligation, to buy a specific number of shares at a predetermined price within a set time. Think of it like a refundable reservation to purchase a stock later at today’s agreed price: investors use calls to profit from expected price rises with smaller upfront cost than buying the stock outright, or to hedge and manage exposure, while the most they can lose is the amount paid for the contract.
deemed outstandingregulatory
"deemed outstanding for this purpose"
Rule 13d-3(d)(1)(i)regulatory
"pursuant to Rule 13d-3(d)(1)(i)"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many shares did Jorey Chernett beneficially own in STLN?
Jorey Chernett reported beneficial ownership of 5,934,872 shares, approximately 5.6% of the class, as of November 13, 2026. The amount comprised 2,641,272 shares held directly and 3,293,600 shares issuable upon exercise of call options exercisable within 60 days.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
STARLING ONCOLOGY, INC.
(Name of Issuer)
Common Stock, $0.001 Par Value Per Share
(Title of Class of Securities)
30068X103
(CUSIP Number)
11/13/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
30068X103
1
Names of Reporting Persons
Chernett Jorey
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
5,934,872.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
5,934,872.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
5,934,872.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
5.6 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: Consists of (i) 2,641,272 shares of Common Stock held directly by the Reporting Person and (ii) 3,293,600 shares of Common Stock issuable upon exercise of call options held by the Reporting Person that are exercisable within 60 days.
Address or principal business office or, if none, residence:
The principal business address of the Reporting Person is 6222 Indianwood Trail, Bloomfield Hills, MI 48301.
(c)
Citizenship:
US
(d)
Title of class of securities:
Common Stock, $0.001 Par Value Per Share
(e)
CUSIP No.:
30068X103
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
As of the close of business on November 13, 2026, the Reporting Person beneficially owned 5,934,872 shares of Common Stock, par value $0.0001 per share, of the Issuer (the "Shares"), consisting of (i) 2,641,272 Shares held directly and (ii) 3,293,600 Shares issuable upon exercise of call options held by the Reporting Person that are exercisable within 60 days.
(b)
Percent of class:
The aggregate percentage of Shares owned by the Reporting Person is based upon 101,991,024 Shares outstanding as of [date], as disclosed in the Issuer's Quarterly Report on Form 10-Q, filed with the U.S. Securities and Exchange Commission (the "SEC") on [date], plus 3,293,600 Shares issuable upon exercise of the call options described in Item 4(a), which are deemed outstanding for this purpose pursuant to Rule 13d-3(d)(1)(i) under the Securities Exchange Act of 1934, as amended.
As of the close of business on November 13, 2026, the Reporting Person may be deemed to beneficially own approximately 5.6% of the outstanding Shares.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
See Cover Pages Items 5-9.
(ii) Shared power to vote or to direct the vote:
See Cover Pages Items 5-9.
(iii) Sole power to dispose or to direct the disposition of:
See Cover Pages Items 5-9.
(iv) Shared power to dispose or to direct the disposition of:
See Cover Pages Items 5-9.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.